SEARCH

SEARCH BY CITATION

References

  • Akaike, H. (1974) A new look at the statistical model identification. IEEE Trans Automat Contr 19, 716723.
  • Ardekani, A. M., Greenberger, J. S. & Jahroudi, N. (1998) Two repressor elements inhibit expression of the von Willebrand factor gene promoter in vitro. Thromb Haemost 80, 488494.
  • Cuppen, E. (2007) Genotyping by Allele-Specific Amplification (KASPar). Utrecht : Hubrecht Laboratorium.
  • Gill, J. C., Endresbrooks, J., Bauer, P. J., Marks, W. J. & Montgomery, R. R. (1987) The effect of Abo blood-group on the diagnosis of Von Willebrand disease. Blood 69, 16911695.
  • Ginsburg, D., Handin, R. I., Bonthron, D. T., Donlon, T. A., Bruns, G. A. P., Latt, S. A. & Orkin, S. H. (1985) Human Vonwillebrand-factor (Vwf) – isolation of complementary-Dna (Cdna) clones and chromosomal localization. Science 228, 14011406.
  • Harvey, P. J., Keightley, A. M., Lam, Y. M., Cameron, C. & Lillicrap, D. (2000) A single nucleotide polymorphism at nucleotide-1793 in the von Willebrand factor (VWF) regulatory region is associated with plasma VWF: Ag levels. Br J Haematol 109, 349353.
  • Kadir, R. A., Economides, D. L., Sabin, C. A., Owens, D. & Lee, C. A. (1999) Variations in coagulation factors in women: Effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost 82, 14561461.
  • Keating, B. J., Tischfield, S., Murray, S. S., Bhangale, T., Price, T. S., Glessner, J. T., Galver, L., Barrett, J. C., Grant, S. F. A., Farlow, D. N., Chandrupatla, H. R., Hansen, M., Ajmal, S., Papanicolaou, G. J., Guo, Y. R., Li, M. Y., DerOhannessian, S., de Bakker, P. I. W., Bailey, S. D., Montpetit, A., Edmondson, A. C., Taylor, K., Gai, X. W., Wang, S. S., Fornage, M., Shaikh, T., Groop, L., Boehnke, M., Hall, A. S., Hattersley, A. T., Frackelton, E., Patterson, N., Chiang, C. W. K., Kim, C. E., Fabsitz, R. R., Ouwehand, W., Price, A. L., Munroe, P., Caulfield, M., Drake, T., Boerwinkle, E., Reich, D., Whitehead, A. S., Cappola, T. P., Samani, N. J., Lusis, A. J., Schadt, E., Wilson, J. G., Koenig, W., McCarthy, M. I., Kathiresan, S., Gabriel, S. B., Hakonarson, H., Anand, S. S., Reilly, M., Engert, J. C., Nickerson, D. A., Rader, D. J., Hirschhorn, J. N. & FitzGerald, G. A. (2008) Concept, design and implementation of a cardiovascular gene-centric 50 K SNP array for large-scale genomic association studies. PLoS One 3(10), e3583, doi:10.1371/journal.pone.0003583.
  • Keightley, A. M., Lam, Y. M., Brady, J. N., Cameron, C. L. & Lillicrap, D. (1999) Variation at the von Willebrand Factor (vWF) gene locus is associated with plasma vWF: Ag levels: Identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 93, 42774283.
  • Kleinschmidt, A. M., Nassiri, M., Stitt, M. S., Wasserloos, K., Watkins, S. C., Pitt, B. R. & Jahroudi, N. (2008) Sequences in intron 51 of the von Willebrand factor gene target promoter activation to a subset of lung endothelial cells in transgenic mice. J Biol Chem 283, 27412750.
  • Kroner, P. A, Foster, P. A., Fahs, S. A. & Montgomery, R. R. (1996) The defective interaction between von Willebrand factor and factor VIII in a patient with type 1 von Willebrand disease is caused by substitution of Arg19 and His54 in mature von Willebrand factor. Blood 87, 10131021.
  • Kumari, M., Marmot, M. & Brunner, E. (2000) Social determinants of von Willebrand factor – The Whitehall II Study. Arterioscler Thromb Vasc Biol 20, 18421847.
  • Lacquemant, C., Gaucher, C., Delorme, C., Chatellier, G., Gallois, Y., Rodier, M., Passa, P., Balkau, B., Mazurier, C., Marre, M. & Froguel, P. (2000) Association between high von Willebrand factor levels and the Thr789Ala vWF gene polymorphism but not with nephropathy in type I diabetes. The GENEDIAB Study Group and the DESIR Study Group. Kidney Int 57, 14371443.
  • Laird, R., Schneider, P. M. & Gaudieri, S. (2007) Forensic STRs as potential disease markers: A study of VWA and von Willebrand's Disease. Forensic Sci Int-Genet 1, 253261.
  • Lawlor, D. A., Bedford, C., Taylor, M. & Ebrahim, S. (2003a) Geographical variation in cardiovascular disease, risk factors, and their control in older women: British Women's Heart and Health Study. J Epidemiol Commun Health 57, 134140.
  • Majerus, E. M., Anderson, P. J. & Sadler, J. E. (2005) Binding of ADAMTS13 to von Willebrand factor. J Biol Chem 280, 2177321778.
  • Marmot, M. & Brunner, E. (2005) Cohort profile: The Whitehall II study. Int J Epidemiol 34, 251256.
  • Marmot, M. G., Smith, G. D., Stansfeld, S., Patel, C., North, F., Head, J., White, I., Brunner, E. & Feeney, A. (1991) Health inequalities among British civil-servants – the Whitehall-II study. Lancet 337, 13871393.
  • Matsui, T., Titani, K. & Mizuochi, T. (1992) Structures of the asparagine-linked oligosaccharide chains of human von Willebrand factor. Occurrence of blood group A, B, and H(O) structures. J Biol Chem 5, 87238731.
  • May, M., Lawlor, D. A., Patel, R., Rumley, A., Lowe, G. & Ebrahim, S. (2007) Associations of von Willebrand factor, fibrin D-dimer and tissue plasminogen activator with incident coronary heart disease: British Women's Heart and Health cohort study. Eur J Cardiovasc Prev Rehabil 14, 638645.
  • Miller, S. A., Dykes, D. D. & Polesky, H. F. (1988) A simple salting out procedure for extracting Dna from human nucleated cells. Nucleic Acids Res 16, 1215.
  • Moeller, A., Weippert-Kretschmer, M., Prinz, H. & Kretschmer, V. (2001) Influence of ABO blood groups on primary hemostasis. Transfusion 41, 5660.
  • Power, C. & Elliott, J. (2006) Cohort profile: 1958 British Birth Cohort (National Child Development Study). Int J Epidemiol 35, 3441.
  • Purcell, S., Neale, B., Todd-Brown, K., Thomas, L., Ferreira, M. A. R., Bender, D., Maller, J., Sklar, P., de Bakker, P. I. W., Daly, M. J. & Sham, P. C. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81, 559575.
  • Rudnicka, A. R., Rumley, A., Lowe, G. D. O. & Strachan, D. P. (2007) Diurnal, seasonal, and blood-processing patterns in levels of circulating fibrinogen, fibrin D-dimer, C-reactive protein, tissue plasminogen activator, and von Willebrand factor in a 45-year-old population. Circulation 115, 9961003.
  • Scheet, P. & Stephens, M. (2006) A fast and flexible statistical model for large-scale population genotype data: Applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78, 629644.
  • Smith, N. L., Chen, M. H., Dehghan, A., Strachan, D. P., Basu, S., Soranzo, N., Hayward, C., Rudan, I., Sabater-Lleal, M., Bis, J. C., de Maat, M. P. M., Rumley, A., Kong, X. X., Yang, Q., Williams, F. M. K., Vitart, V., Campbell, H., Malarstig, A., Wiggins, K. L., Van Duijn, C. M., McArdle, W. L., Pankow, J. S., Johnson, A. D., Silveira, A., McKnight, B., Uitterlinden, A. G., Aleksic, N., Meigs, J. B., Peters, A., Koenig, W., Cushman, M., Kathiresan, S., Rotter, J. I., Bovill, E. G., Hofman, A., Boerwinkle, E., Tofler, G. H., Peden, J. F., Psaty, B. M., Leebeek, F., Folsom, A. R., Larson, M. G., Spector, T. D., Wright, A. F., Wilson, J. F., Hamsten, A., Lumley, T., Witteman, J. C. M., Tang, W. H. & O’Donnell, C. J. (2010) Novel associations of multiple genetic loci with plasma levels of factor VII, factor VIII, and von Willebrand factor the CHARGE (Cohorts for heart and aging research in genome epidemiology) consortium. Circulation 121, 13821392.
  • Spiel, A. O., Gilbert, J. C. & Jilma, B. (2008) Von Willebrand factor in cardiovascular disease focus on acute coronary syndromes. Circulation 117, 14491459.
  • Talmud, P. J., Drenos, F., Shah, S., Shah, T., Palmen, J., Verzilli, C., Gaunt, T. R., Pallas, J., Lovering, R., Li, K., Casas, J. P., Sofat, R., Kumari, M., Rodriguez, S., Johnson, T., Newhouse, S. J., Dominiczak, A., Samani, N. J., Caulfield, M., Sever, P., Stanton, A., Shields, D. C., Padmanabhan, S., Melander, O., Hastie, C., Delles, C., Ebrahim, S., Marmot, M. G., Smith, G. D., Lawlor, D. A., Munroe, P. B., Day, I. N., Kivimaki, M., Whittaker, J., Humphries, S. E. & Hingorani, A. D. (2009) Gene-centric association signals for lipids and apolipoproteins identified via the HumanCVD BeadChip. Am J Hum Genet 85, 628642.
  • Van Schie, M. C., de Maat, M. P. M., Isaacs, A., van Duijn, C. M., Deckers, J. W., Dippel, D. W. J. & Leebeek, F. W. G. (2010) Variation in the von Willebrand Factor gene is associated with VWF levels and with the risk of cardiovascular disease. Blood doi:10.1182/blood-2010-03-273961.
  • Walker, M., Whincup, P. H. & Shaper, A. G. (2004) The British regional heart study 1975–2004. Int J Epidemiol 33, 11851192.
  • Wannamethee, S. G., Whincup, P. H., Shaper, A. G., Rumley, A., Lennon, L. & Lowe, G. D. O. (2009) Circulating inflammatory and hemostatic biomarkers are associated with risk of myocardial infarction and coronary death, but not angina pectoris, in older men. J Thromb Haemost 7, 16051611.
  • Whincup, P. H., Danesh, J., Walker, M., Lennon, L., Thomson, A., Appleby, R., Rumley, A. & Lowe, G. D. O. (2002) von Willebrand factor and coronary heart disease – Prospective study and meta-analysis. Eur Heart J 23, 17641770.